Meghmani Organics still playing safe from Coronavirus
Meghmani Organics still playing safe from Coronavirus

Meghmani Organics still playing safe from Coronavirus

Pratik Shastri Article rating: 2.7

Though the company added that it has adequate inventory for current quarter, its large operational season starts in June, which can be expected to be little worrisome for the company if the virus-related shutdown in China is not dissolved.

MF Update: Yes Bank holdings affect mutual funds
MF Update: Yes Bank holdings affect mutual funds

MF Update: Yes Bank holdings affect mutual funds

Henil Shah Article rating: 4.0

Due to a concern over Yes Bank’s survival and honouring of its debt obligations, MFs holding the debt instruments of Yes Bank would get affected. Read on to find out more.

Rupee weakens again as Coronavirus fear continues
Rupee weakens again as Coronavirus fear continues

Rupee weakens again as Coronavirus fear continues

Apurva Joshi Article rating: 5.0

Indian rupee weakened against US dollar on Friday, followed by continued foreign fund outflows and weak domestic equities amid a sell-off across the globe as the spread of Coronavirus pandemic stoked fears of recession.

Capital-starved Yes Bank tanks 85 per cent
Capital-starved Yes Bank tanks 85 per cent

Capital-starved Yes Bank tanks 85 per cent

Amir Shaikh Article rating: 4.4

Capital-starved Yes Bank has tumbled more than 85 per cent on the bourses today as the country's central bank has imposed a moratorium on the bank and capped withdrawals at Rs 50,000 per account 

Dr Reddys Laboratories plunge post USFDA audit in Plant-5
Dr Reddys Laboratories plunge post USFDA audit in Plant-5

Dr Reddys Laboratories plunge post USFDA audit in Plant-5

Avalokita Pandey Article rating: 4.7

The shares of Dr Reddy’s Laboratories plunged today after the multinational pharmaceutical company announced on Thursday that an audit has been conducted at its API manufacturing Plant-5 in Telangana by USFDA, after which, the agency issued a form 483 with three observations.

The downside protection myth!
The downside protection myth!

The downside protection myth!

Henil Shah Article rating: 3.0

Downside risk is something that investors look for reducing the risk of loss during the worst time and they feel active managers can do it better. This is a myth that needs to get busted.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 5.0

The market opened in the red on March 6, 2020, overall volumes in futures & options currently stand at 5,72 crore contracts with a turnover of Rs. 37,12,514.30 crore.

Stocks with buying interest
Stocks with buying interest

Stocks with buying interest

Abhishek Kapoor Article rating: 4.2

The market opened in the red on March 6, 2020, overall volumes in futures & options currently stand at 5,72 crore contracts with a turnover of Rs. 37,12,514.30 crore.

Lupin launches generic version of Vimovo in US
Lupin launches generic version of Vimovo in US

Lupin launches generic version of Vimovo in US

Anthony Fernandes Article rating: 4.0

Pharma major Lupin Limited announced the launch of an authorised generic version of Horizon Therapeutics PLC's Vimovo delayed action release tablets, 375 mg/20 mg and 500 mg/ 20 mg in US.

RSS
First22252226222722282230223222332234Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR